ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m

By Yahoo! Finance   |   2 years ago
ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m

ALK-Abelló has acquired Neffy adrenaline nasal spray rights in Europe and Canada from ARS Pharmaceuticals for $145m. ALK plans to launch Neffy in Europe in 2025 and aims for peak sales of $332.8m.

Read More

Did you find this insightful?